ID

26340

Descripción

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacogenetic research Withdrawal of consent

Palabras clave

  1. 9/10/17 9/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 11/1/18 11/1/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

16 de octubre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :


Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Pharmacogenetic research Withdrawal of consent GSK study Chronic Coronary Heart Disease NCT00799903

Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

Withdrawal of consent for PGx (DNA) / Blood sample destruction
Descripción

Withdrawal of consent for PGx (DNA) / Blood sample destruction

1. Has subject withdrawn consent for PGx research?
Descripción

withdrawal consent for PGx research

Tipo de datos

boolean

If subject has withdrawn consent for PGx research: date informed consent withdrawn
Descripción

date informed consent withdrawn

Tipo de datos

date

2. Has a request been made for blood sample destruction?
Descripción

request for blood sample destruction

Tipo de datos

boolean

If a request has been made for blood sample destruction, check reason
Descripción

request for blood sample destruction reason

Tipo de datos

text

If other reason applied, specify
Descripción

request for blood sample destruction other reason

Tipo de datos

text

Similar models

Pharmacogenetic research Withdrawal of consent Subject Identification GSK study Chronic Coronary Heart Disease NCT00799903

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Withdrawal of consent for PGx (DNA) / Blood sample destruction
withdrawal consent for PGx research
Item
1. Has subject withdrawn consent for PGx research?
boolean
date informed consent withdrawn
Item
If subject has withdrawn consent for PGx research: date informed consent withdrawn
date
request for blood sample destruction
Item
2. Has a request been made for blood sample destruction?
boolean
Item
If a request has been made for blood sample destruction, check reason
text
Code List
If a request has been made for blood sample destruction, check reason
CL Item
Subject withdrew consent for PGx (3)
CL Item
Other (Z)
request for blood sample destruction other reason
Item
If other reason applied, specify
text

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial